Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

166.31
+0.02000.01%
Post-market: 166.310.00000.00%16:10 EST
Volume:477.88K
Turnover:79.73M
Market Cap:10.11B
PE:-27.46
High:168.93
Open:167.09
Low:165.62
Close:166.29
52wk High:182.99
52wk Low:95.49
Shares:60.77M
Float Shares:58.65M
Volume Ratio:0.63
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0558
EPS(LYR):8.65
ROE:-9.06%
ROA:4.88%
PB:2.55
PE(LYR):19.23

Loading ...

Jazz Pharmaceuticals plc announces upcoming financial results webcast

Reuters
·
Feb 11

ALX Oncology Reports CD47 Biomarker Predicts Response to Evorpacept in Advanced HER2-Positive Breast Cancer

Reuters
·
Jan 30

Analysts Offer Insights on Healthcare Companies: Palvella Therapeutics (PVLA), Nurix Therapeutics (NRIX) and Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
Jan 29

Jazz Pharmaceuticals Plc : TD Cowen Raises Target Price to $220 From $205

THOMSON REUTERS
·
Jan 29

Analysts Have Conflicting Sentiments on These Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and AbbVie (ABBV)

TIPRANKS
·
Jan 16

Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA), Jazz Pharmaceuticals (JAZZ) and Annexon Biosciences (ANNX)

TIPRANKS
·
Jan 16

Jazz Pharmaceuticals Showcases Rare Disease Breakthroughs and Growth Strategy in New Presentation

Reuters
·
Jan 14

Jazz Pharmaceuticals (JAZZ) Gets a Buy from Jefferies

TIPRANKS
·
Jan 13

BRIEF-Jazz Pharmaceuticals PLC - Expects To Meet 2025 Revenue Guidance - SEC Filing

Reuters
·
Jan 12

Jazz Pharmaceuticals Plc - Expects to Meet 2025 Revenue Guidance - SEC Filing

THOMSON REUTERS
·
Jan 12

Jazz Pharmaceuticals Completes Acquisition of Chimerix

Reuters
·
Jan 12

Jazz Pharmaceuticals price target raised to $235 from $210 at Needham

TIPRANKS
·
Jan 12

Truist Raises Price Target on Jazz Pharmaceuticals to $230 From $220, Keeps Buy Rating

MT Newswires Live
·
Jan 12

Boehringer Ingelheim: Phase 1B Study to Evaluate Combination of Zongertinib and Zanidatamab in Her2-Positive Breast Cancer Patients

THOMSON REUTERS
·
Jan 12

Jazz Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Jan 12

U.S. RESEARCH ROUNDUP-American Express, Ameriprise Financial, Mastercard

Reuters
·
Jan 12

Jazz Pharmaceuticals Plc : Needham Raises Target Price to $235 From $210

THOMSON REUTERS
·
Jan 12

Jazz Pharmaceuticals Plc : Truist Securities Raises Target Price to $230 From $220

THOMSON REUTERS
·
Jan 12

Is Jazz Pharmaceuticals (JAZZ) Still Attractive After 33% Share Price Gain This Year?

Simply Wall St.
·
Jan 11

Jazz Pharmaceuticals Names Chief Business Officer

MT Newswires Live
·
Jan 09